Japan’s New Pharmaceutical Law Prompts Drug Makers To Change Packaging To Appeal To Retailers That Can Now Sell Class I Drugs
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Takeda Pharmaceutical has begun offering smaller packages of its over-the-counter drugs for convenience stores and other small retailers in response to the enforcement of the amended Pharmaceutical Administration Law, in moves that industry officials said will be emulated in coming months
You may also be interested in...
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required.)